Demethoxycurcumin, a major active curcuminoid from Curcuma longa, suppresses balloon injury induced vascular smooth muscle cell migration and neointima formation: An in vitro and in vivo study

Molecular Nutrition and Food Research

Volumn 57, Issue 9, 2013, Pages 1586-1597

  Sheu, Ming Jyh ^a   Lin, Hui Yi ^a   Yang, Yi Hsuan ^a   Chou, Chia Ju ^a   Chien, Yi Chung ^b   Wu, Tian Shung ^a,c   Wu, Chieh Hsi ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Demethoxycurcumin; Matrix metalloproteinase; Migration; Restenosis; Vascular smooth muscle cells

Indexed keywords

CURCUMA LONGA; RATTUS;

CURCUMIN; CYCLINE; DEMETHOXYCURCUMIN; DRUG DERIVATIVE; GELATINASE A; GELATINASE B; GRP58 PROTEIN, RAT; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOGLYCERATE KINASE; PROTEIN DISULFIDE ISOMERASE; PROTEIN KINASE B;

ANIMAL; ARTICLE; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CURCUMA; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENETICS; MALE; METABOLISM; MIGRATION; NEOINTIMA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHOSPHORYLATION; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELLS;

DEMETHOXYCURCUMIN; MATRIX METALLOPROTEINASE; MIGRATION; RESTENOSIS; VASCULAR SMOOTH MUSCLE CELLS;

ANGIOPLASTY, BALLOON; ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CURCUMA; CURCUMIN; DOWN-REGULATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOGLYCERATE KINASE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN DISULFIDE-ISOMERASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84883454684     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200462     Document Type: Article

References (38)

1. Grüntzig, A. R., Senning, A., Siegenthaler, W. E., Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 1979, 301, 61-68.
2. Bauters, C., Lablanche, J. M., McFadden, E., Leroy, F. et al., Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis. J. Am. Coll. Cardiol. 1992, 20, 845-848.
3. McBride, W., Lange, R. A., Hillis, L. D., Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N. Engl. J. Med. 1988, 318, 1734-1737.
4. Bisht, S., Maitra, A., Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 2009, 6, 192-199.
5. Maheshwari, R. K., Singh, A. K., Gaddipati, J., Srimal, R. C., Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78, 2081-2087.
6. Zhang, L., Wu, C., Zhao, S., Yuan, D. et al., Demethoxycurcumin, a natural derivative of curcumin attenuates LPS-induced pro-inflammatory responses through down-regulation of intracellular ROS-related MAPK/NF-kappaB signaling pathways in N9 microglia induced by lipopolysaccharide. Int. Immunopharmacol. 2010, 10, 331-338.
7. Kim, A. N., Jeon, W. K., Lee, J. J., Kim, B. C., Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages. Free Radic. Biol. Med. 2010, 49, 323-331.
8. Tanaka, H., Sukhova, G. K., Swanson, S. J., Clinton, S. K. et al., Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88, 1788-1803.
9. Yu, Y. M., Lin, H. C., Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 125-132.
10. Wang, Y. J., Lin, H. Y., Wu, C. H., Liu, D. M., Forming of demethoxycurcumin nanocrystallite-chitosan nanocarrier for controlled low dose cellular release for inhibition of the migration of vascular smooth muscle cells. Mol. Pharm. 2012, 9, 2268-2279.
11. Hung, C. M., Su, Y. H., Lin, H. Y., Lin, J. N. et al., Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR. J. Agric. Food Chem. 2012, 60, 8427-8434.
12. Travo, P., Barrett, G., Burnstock, G., Differences in proliferation of primary cultures of vascular smooth muscle cells taken from male and female rats. Blood Vessels 1980, 17, 110-116.
13. Chien, Y. C., Huang, G. J., Cheng, H. C., Wu, C. H. et al., Hispolon attenuates balloon-injured neointimal formation and modulates vascular smooth muscle cell migration via AKT and ERK phosphorylation. J. Nat. Prod. 2012, 75, 1524-1533
14. Chen, Y. Y., Liu, F. C., Chou, P. Y., Chien, Y. C. et al., Ethanol extracts of fruiting bodies of Antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways. Evid. Based Complem. Altern. Med. 2012, 2012, 378415.
15. Newby, A. C., Zaltsman, A. B., Molecular mechanisms in intimal hyperplasia. J. Pathol. 2000, 190, 300-309.
16. Chen, Y. N., Huang, T. F., Chang, C. H., Hsu, C. C. et al., Antirestenosis effect of butein in the neointima formation progression. J. Agric. Food Chem. 2012, 60, 6832-6838.
17. Hlawaty, H., San Juan, A., Jacob, M. P., Vranckx, R. et al., Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3593-H3601.
18. Jacob, M. P., Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed. Pharmacother. 2003, 57, 195-202.
19. Feldman, L. J., Mazighi, M., Scheuble, A., Deux, J. F. et al., Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation 2001, 103, 3117-3122.
20. Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E. et al., Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2002, 2, 573-583.
21. Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A. et al., Independent expression and cellular processing of Mr 72, 000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990, 50, 6184-6191.
22. Egeblad, M., Werb, Z., New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2, 161-174.
23. Hlawaty, H., Suffee, N., Sutton, A., Oudar, O. et al., Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. Biochem. Pharmacol. 2011, 81, 233-243.
24. Indolfi, C., Coppola, C., Torella, D., Arcucci, O. et al., Gene therapy for restenosis after balloon angioplasty and stenting. Cardiol. Rev. 1999, 7, 324-331.
25. Gennaro, G., Menard, C., Michaud, S. E., Deblois, D. et al., Inhibition of vascular smooth muscle cell proliferation and neointima formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 2004, 110, 3367-3371.
26. Wu, C. H., Lin, C. S., Hung, J. S., Wu, C. J. et al., Inhibition of neointima formation in porcine coronary artery by a Ras mutant. J. Surg. Res. 2001, 99, 100-106.
27. Jonsson, Z. O., Hindges, R., Hubscher, U., Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO J. 1998, 17, 2412-2425.
28. Wei, G. L., Krasinski, K., Kearney, M., Isner, J. M. et al., Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ. Res. 1997, 80, 418-426.
29. Meng, X. N., Jin, Y., Yu, Y., Bai, J. et al., Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br. J. Cancer 2009, 101, 327-334.
30. Renshaw, M. W., Price, L. S., Schwartz, M. A., Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J. Cell. Biol. 1999, 147, 611-618.
31. Liao, H. F., Chen, Y. Y., Liu, J. J., Hsu, M. L. et al., Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J. Agric. Food Chem. 2003, 51, 7907-7912.
32. Ghiselli, G., Chen, J., Kaou, M., Hallak, H. et al., Ethanol inhibits fibroblast growth factor-induced proliferation of aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1808-1813.
33. Choi, K. H., Kim, J. E., Song, N. R., Son, J. E. et al., Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc. Res. 2010, 85, 836-844.
34. Fernandez-Hernando, C., Jozsef, L., Jenkins, D., Di Lorenzo, A. et al., Absence of Akt1 reduces vascular smooth muscle cell migration and survival and induces features of plaque vulnerability and cardiac dysfunction during atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 2033-2040.
35. Seo, J. M., Kim, T. J, Jin, Y. R., Han, H. J. et al., YSK2821, a newly synthesized indoledione derivative, inhibits cell proliferation and cell cycle progression via the cell cycle-related proteins by regulating phosphatidylinositol-3 kinase cascade in vascular smooth muscle cells. Eur. J. Pharmacol. 2008, 586, 74-81.
36. Zieker, D., Königsrainer, I., Traub, F., Nieselt, K. et al., PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol. Biochem. 2008, 21, 429-436.
37. Wang, J., Ying, G., Wang, J., Jung, Y. et al., Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res. 2010, 70, 471-480.
38. Boccardi, C., Cecchettini, A., Caselli, A., Camici, G. et al., A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res. 2007, 329, 119-128.